Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301418 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 51.1 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301473 (1-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29.2 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301420 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14.6 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301421 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20.5 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301421 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.02 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301423 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.48 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301423 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 33.5 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301425 (4-amino-7-{1-[1-(2,5-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301426 (4-amino-7-{1-[1-(3,4-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 28.4 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301427 (4-amino-7-{1-[1-(propan-2-yl)-1H-pyrazol-4-yl]prop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301427 (4-amino-7-{1-[1-(propan-2-yl)-1H-pyrazol-4-yl]prop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.96 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301429 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-pyrazol-4-yl]e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301429 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-pyrazol-4-yl]e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.420 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301431 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-pyrazol-4-yl]p...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301431 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-pyrazol-4-yl]p...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301433 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-pyrazol-4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.420 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301433 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-pyrazol-4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301435 (4-amino-7-{1-[3-(2-fluorophenyl)-1,2-oxazol-5-yl]e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.67 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301435 (4-amino-7-{1-[3-(2-fluorophenyl)-1,2-oxazol-5-yl]e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301437 (4-Amino-7-{1-[1-(2,4-difluorophenyl)-1H-pyrazol-4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.94 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301438 (4-amino-7-{(1R)-1-[1-(2,4-difluorophenyl)-1H-pyraz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.660 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301439 (4-amino-7-{[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 27.1 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301420 (4-amino-7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-tria...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20.9 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301421 (4-amino-7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.86 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301442 (4-amino-7-{[1-(2-fluorophenyl)-1H-pyrazol-4-yl]met...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.860 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301443 (4-amino-5-[2-(difluoromethyl)pyrimidin-5-yl]-7-{[1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.05 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301444 (4-Amino-7-{[3-(2-fluorophenyl)-1,2-oxazol-5-yl]met...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301445 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]eth...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301445 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]eth...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.48 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301447 (7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 225 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301447 (7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.48 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301449 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301449 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 36.6 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301451 (7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 115 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301451 (7-{1-[1-(2,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301453 (7-{1-[1-(2,5-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 73.7 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301453 (7-{1-[1-(2,5-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.95 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301455 (7-{1-[1-(3,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19.3 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301455 (7-{1-[1-(3,4-difluorophenyl)-1H-1,2,3-triazol-4-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 177 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301457 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10.4 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301458 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 123 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301459 (1-{4-amino-5-[2-(trifluoromethyl)pyrimidin-5-yl]py...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301449 (7-{1-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.93 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301462 (7-{1-[1-(2-Fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301463 (BDBM301464 | US10131670, Example 87 | {1-[1-(2-Flu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.53 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301463 (BDBM301464 | US10131670, Example 87 | {1-[1-(2-Flu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301465 (1-{1-[1-(2-Fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 189 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301465 (1-{1-[1-(2-Fluorophenyl)-1H-1,2,3-triazol-4-yl]pro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31.5 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301467 (5-(4-Chlorophenyl)-7-{[1-(2-fluorophenyl)-1H-1,2,3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 116 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator (Homo sapiens (Human)) | BDBM301468 (1-[1-(1-phenyl-1H-1,2,3-triazol-4-yl)propyl]-3-[2-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 74.4 | n/a | n/a | n/a | n/a |
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. US Patent | Assay Description Primary cystic fibrosis human bronchial epithelial (CF hBE) cells were expanded and cultured according to published methods (Neuberger et al., Ch. 4 ... | US Patent US10131670 (2018) BindingDB Entry DOI: 10.7270/Q29025VF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 55 total ) | Next | Last >> |